This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Apr;28(4):277-8.

doi: 10.1046/j.1365-2362.1998.00290.x.

Increased incidence of cardiovascular diseases in primary hyperparathyroidism--a cause for more aggressive treatment?

F Raue¹

Affiliations

PMID: 9615903
DOI: 10.1046/j.1365-2362.1998.00290.x

Comment

Increased incidence of cardiovascular diseases in primary hyperparathyroidism--a cause for more aggressive treatment?

F Raue. Eur J Clin Invest. 1998 Apr.

. 1998 Apr;28(4):277-8.

doi: 10.1046/j.1365-2362.1998.00290.x.

Author

F Raue¹

Affiliation

¹ Endokrinologische Gemeinschaftspraxis, Heidelberg, Germany.

PMID: 9615903
DOI: 10.1046/j.1365-2362.1998.00290.x

No abstract available

PubMed Disclaimer

Comment on

Increased risk of death from primary hyperparathyroidism--an update.
Hedbäck G, Odén A. Hedbäck G, et al. Eur J Clin Invest. 1998 Apr;28(4):271-6. doi: 10.1046/j.1365-2362.1998.00289.x. Eur J Clin Invest. 1998. PMID: 9615902

Similar articles

[Primary hyperparathyroidism--occurrence, symptoms, complications and treatment].
Bollerslev J, Ogard CG, Schwarz P, Vestergaard H, Vestergaard P. Bollerslev J, et al. Ugeskr Laeger. 2005 Feb 21;167(8):910-4. Ugeskr Laeger. 2005. PMID: 15789847 Review. Danish. No abstract available.
Asymptomatic primary hyperparathyroidism.
Birkenhäger JC, Bouillon R. Birkenhäger JC, et al. Postgrad Med J. 1996 Jun;72(848):323-6. doi: 10.1136/pgmj.72.848.323. Postgrad Med J. 1996. PMID: 8758007 Free PMC article. Review.
[Hyperparathyroidism as a cardiovascular risk factor in chronic kidney disease: an update from a biological-cellular perspective].
Vezzoli G, Arcidiacono T, Rainone F, Terranegra A, Aloia A, Dogliotti E, Mingione A, Soldati L, Spotti D. Vezzoli G, et al. G Ital Nefrol. 2011 Jul-Aug;28(4):383-92. G Ital Nefrol. 2011. PMID: 21809307 Review. Italian.
Editorial: cardiovascular disease in primary hyperparathyroidism.
Silverberg SJ. Silverberg SJ. J Clin Endocrinol Metab. 2000 Oct;85(10):3513-4. doi: 10.1210/jcem.85.10.6927. J Clin Endocrinol Metab. 2000. PMID: 11061492 No abstract available.
Impaired vascular reactivity in primary hyperparathyroidism may contribute to cardiovascular risk.
Smith JC, Evans LM, Cockcroft JR, Davies JS. Smith JC, et al. Clin Endocrinol (Oxf). 2001 Aug;55(2):279-80. doi: 10.1046/j.1365-2265.2001.01225.x. Clin Endocrinol (Oxf). 2001. PMID: 11531938 No abstract available.

See all similar articles

Cited by

Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results.
Luigi P, Chiara FM, Laura Z, Cristiano M, Giuseppina C, Luciano C, Giuseppe P, Sabrina C, Susanna S, Antonio C, Giuseppe C, Giorgio de T, Claudio L. Luigi P, et al. Int J Endocrinol. 2012;2012:408295. doi: 10.1155/2012/408295. Epub 2012 Jun 7. Int J Endocrinol. 2012. PMID: 22719761 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley